Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.

IOZK presentation: Modulated electro-hyperthermia in the treatment of children with DIPG at the annual conference of the ESHO at the Charité in Berlin

IOZK publication in the International Journal of Molecular Sciences by Prof. Schirrmacher focusing on the role of Newcastle Disease Virus in tumor vaccinations